Skip to main content

Animations

MJFF Publications

5181 - 5190 of 6431 Results
Title
Year
  • Year
  • 2018
  • 2015
  • 2019
  • 2022
  • 2014
  • 2016
  • 2016
  • 2025
  • 2019
  • 2017
  • Summary Details
    OPEN
    Title: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066
    Citation Count: 719
  • Summary Details
    OPEN
    Title: A lipid switch unlocks Parkinson’s disease-associated ATP13A2
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1508220112
    Citation Count: 91
  • Summary Details
    OPEN
    Title: The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.113062
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Constitutive nuclear accumulation of endogenous alpha-synuclein in mice causes motor impairment and cortical dysfunction, independent of protein aggregation
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1093/hmg/ddac035
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.10.008
    Citation Count: 103
  • Summary Details
    OPEN
    Title: A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2016.04.001
    Citation Count: 85
  • Summary Details
    OPEN
    Title: Cognitive phenotypes in parkinson's disease differ in terms of brain‐network organization and connectivity
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/hbm.23474
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Pathological α-synuclein perturbs nuclear integrity
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107028
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.1900289116
    Citation Count: 78
  • Summary Details
    OPEN
    Title: A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1007/s13311-017-0544-9
    Citation Count: 54
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.